06/10/2026
That’s a wrap on EURETINA 2026!
From packed sessions and thought-provoking discussions to brilliant meetings with colleagues, partners and members of the wider retinal community, EURETINA 2026 was a fantastic opportunity to connect, share and learn.
We were delighted to share more about our work across research, patient experience, advocacy, policy and innovation, and to bring the patient perspective into conversations around the future of retinal care and therapeutic development.
A huge thank you to everyone who took the time to meet with us, attend our sessions, share their expertise and engage in the conversations.
And a special shoutout to our RI team who represented us throughout the congress:
Franz Badura, Board Chair
Avril Daly, CEO
Dr Nabin Paudel, Director of Research, Patient Evidence & Programmes
Dr Ellen Moran, Head of Scientific Affairs
From European policy and emerging therapies to patient-centred research, meaningful outcomes and the future of retinal innovation, there was plenty to discuss, and plenty to take back with us.
Thank you, team EURETINA, for bringing the retinal community together! Looking forward to the next one already!
ID1: Left to Right - Ellen Moran, Nabin Paudel and Avril Daly in front of VIECON Convention Centre with EURETINA branding.
ID2: Dr Nabin Paudel from RI, presenting findings from our Mental Study at EURETINA.
ID3: Left to right - Avril Daly, Helene Dollfus, Franz Badura, and Nicole Eter at RI and EURETINA Joint Session.
ID4: Avril Daly presenting at the Retina International Partner Meeting at EURETINA.
ID5: Avril Daly presenting at EURETINA - Top Tips for Patient Consult.